{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:47:15Z","timestamp":1793170035109,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U01DA038360-Z0717001"],"award-info":[{"award-number":["U01DA038360-Z0717001"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG1DA040309"],"award-info":[{"award-number":["UG1DA040309"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.drugpo.2019.09.008","type":"journal-article","created":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T06:01:35Z","timestamp":1570168895000},"page":"144-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"special_numbering":"C","title":["Barriers to naloxone use and acceptance among opioid users, first responders, and emergency department providers in New Hampshire, USA"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4588-827X","authenticated-orcid":false,"given":"Sarah","family":"Bessen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Metcalf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2728-0001","authenticated-orcid":false,"given":"Elizabeth C.","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah K.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany","family":"McLeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Marsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugpo.2019.09.008_bib0001","series-title":"Provisional drug overdose death counts","author":"Ahmad","year":"2019"},{"key":"10.1016\/j.drugpo.2019.09.008_bib0002","series-title":"Executive summary of New Hampshire statewide naloxone and distribution training initiative","year":"2016"},{"key":"10.1016\/j.drugpo.2019.09.008_bib0003","series-title":"New Hampshire pharmacies with standing orders","year":"2017"},{"key":"10.1016\/j.drugpo.2019.09.008_bib0004","series-title":"ATLAS.ti (Version 8.1)","year":"2017"},{"issue":"1","key":"10.1016\/j.drugpo.2019.09.008_bib0005","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1176\/appi.ps.201700235","article-title":"Fentanyl and the evolving opioid epidemic: What strategies should policy makers consider?","volume":"69","author":"Barry","year":"2018","journal-title":"Psychiatric Services"},{"issue":"5","key":"10.1016\/j.drugpo.2019.09.008_bib0006","doi-asserted-by":"crossref","first-page":"788","DOI":"10.2105\/AJPH.2008.146647","article-title":"Saved by the nose: Bystander-administered intranasal naloxone hydrochloride for opioid overdose","volume":"99","author":"Doe-Simkins","year":"2009","journal-title":"American Journal of Public Health"},{"issue":"3","key":"10.1016\/j.drugpo.2019.09.008_bib0007","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/07399339209516006","article-title":"Content analysis: Method, applications, and issues","volume":"13","author":"Downe-Wamboldt","year":"1992","journal-title":"Health Care for Women International"},{"issue":"4","key":"10.1016\/j.drugpo.2019.09.008_bib0008","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s13181-014-0432-1","article-title":"Expanding access to naloxone in the United States","volume":"10","author":"Doyon","year":"2014","journal-title":"Journal of Medical Toxicology"},{"issue":"1","key":"10.1016\/j.drugpo.2019.09.008_bib0009","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1186\/s13104-016-2268-z","article-title":"Why is it so hard to implement change? A qualitative examination of barriers and facilitators to distribution of naloxone for overdose prevention in a safety net environment","volume":"9","author":"Drainoni","year":"2016","journal-title":"BMC Research Notes"},{"key":"10.1016\/j.drugpo.2019.09.008_bib0010","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.drugpo.2017.06.005","article-title":"Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic","volume":"46","author":"Fairbairn","year":"2017","journal-title":"International Journal of Drug Policy"},{"issue":"5","key":"10.1016\/j.drugpo.2019.09.008_bib0011","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.addbeh.2005.07.020","article-title":"Provision of naloxone to injection drug users as an overdose prevention strategy: Early evidence from a pilot study in New York City","volume":"31","author":"Galea","year":"2006","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.drugpo.2019.09.008_bib0012","series-title":"The sage encyclopedia of qualitative research methods (Vol.\u00a02)","year":"2008"},{"issue":"2s","key":"10.1016\/j.drugpo.2019.09.008_bib0013","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.japh.2017.01.013","article-title":"Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states","volume":"57","author":"Green","year":"2017","journal-title":"Journal of the American Pharmacists Association"},{"issue":"2","key":"10.1016\/j.drugpo.2019.09.008_bib0014","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.drugalcdep.2013.08.018","article-title":"Law enforcement attitudes toward overdose prevention and response","volume":"133","author":"Green","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.drugpo.2019.09.008_bib0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/08897077.2015.1129390","article-title":"Assessment of provider attitudes toward #naloxone on Twitter","volume":"37","author":"Haug","year":"2016","journal-title":"Substance Abuse"},{"issue":"9","key":"10.1016\/j.drugpo.2019.09.008_bib0016","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1177\/1049732305276687","article-title":"Three approaches to qualitative content analysis","volume":"15","author":"Hsieh","year":"2005","journal-title":"Qualitative Health Research"},{"key":"10.1016\/j.drugpo.2019.09.008_bib0017","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jsat.2016.07.005","article-title":"Awareness and attitudes toward intranasal naloxone rescue for opioid overdose prevention","volume":"69","author":"Kirane","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.drugpo.2019.09.008_bib0018","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10900-012-9591-7","article-title":"Injection drug users trained by overdose prevention programs: Responses to witnessed overdoses","volume":"38","author":"Lankenau","year":"2013","journal-title":"Journal of Community Health"},{"issue":"3","key":"10.1016\/j.drugpo.2019.09.008_bib0019","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.17269\/cjph.104.3788","article-title":"Development and implementation of an opioid overdose prevention and response program in Toronto, Ontario","volume":"104","author":"Leece","year":"2013","journal-title":"Canadian Journal of Public Health. Revue Canadienne de Sant\u00e9 Publique"},{"key":"10.1016\/j.drugpo.2019.09.008_bib0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2147\/SAR.S101700","article-title":"Intranasal naloxone and related strategies for opioid overdose intervention by nonmedical personnel: A review","volume":"8","author":"Lewis","year":"2017","journal-title":"Substance Abuse and Rehabilitation"},{"issue":"3","key":"10.1016\/j.drugpo.2019.09.008_bib0021","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/JAN.0000000000000132","article-title":"Combating opioid overdose with public access to naloxone","volume":"27","author":"Mitchell","year":"2016","journal-title":"Journal of Addictions Nursing"},{"issue":"1","key":"10.1016\/j.drugpo.2019.09.008_bib0022","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/104973239300300107","article-title":"Qualitative content analysis: A guide to paths not taken","volume":"3","author":"Morgan","year":"1993","journal-title":"Qualitative Health Research"},{"issue":"2","key":"10.1016\/j.drugpo.2019.09.008_bib0023","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/08897077.2015.1010032","article-title":"A review of opioid overdose prevention and naloxone prescribing: Implications for translating community programming into clinical practice","volume":"36","author":"Mueller","year":"2015","journal-title":"Substance Abuse"},{"key":"10.1016\/j.drugpo.2019.09.008_bib0024","series-title":"Medications for opioid use disorder save lives","year":"2019"},{"key":"10.1016\/j.drugpo.2019.09.008_bib0025","series-title":"New Hampshire opioid summary","year":"2019"},{"key":"10.1016\/j.drugpo.2019.09.008_bib0026","series-title":"Overdose death rates","year":"2019"},{"key":"10.1016\/j.drugpo.2019.09.008_bib0027","series-title":"NDEWS New Hampshire HotSpot report","year":"2016"},{"key":"10.1016\/j.drugpo.2019.09.008_bib0028","series-title":"January 2018 report","year":"2018"},{"key":"10.1016\/j.drugpo.2019.09.008_bib0029","series-title":"May 2019 report","year":"2019"},{"key":"10.1016\/j.drugpo.2019.09.008_bib0030","series-title":"Mid-year report 2018","year":"2018"},{"key":"10.1016\/j.drugpo.2019.09.008_bib0031","unstructured":"New Hampshire Harm Reduction Coalition (NHHRC). NHHRC Website, 2019. Retrieved from http:\/\/nhhrc.org."},{"key":"10.1016\/j.drugpo.2019.09.008_bib0032","series-title":"Chapter 65: An act relative to possession and administration of an opioid antagonist for opioid-related overdoses","year":"2015"},{"key":"10.1016\/j.drugpo.2019.09.008_bib0033","series-title":"Dictionary of nursing theory and research","author":"Powers","year":"2006"},{"key":"10.1016\/j.drugpo.2019.09.008_bib0034","unstructured":"Project 439. Project 439 Website, 2019. Retrieved from http:\/\/project439.com."},{"key":"10.1016\/j.drugpo.2019.09.008_bib0035","series-title":"With a little help from my friends","author":"Rees","year":"2017"},{"key":"10.1016\/j.drugpo.2019.09.008_bib0036","first-page":"21","article-title":"The multiple roles of qualitative research in understanding and responding to illicit drug use","volume":"Vol. 4","author":"Rhodes","year":"2000"},{"issue":"2","key":"10.1016\/j.drugpo.2019.09.008_bib0037","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0955-3959(02)00007-5","article-title":"The \u2018risk environment\u2019: A framework for understanding and reducing drug-related harm","volume":"13","author":"Rhodes","year":"2002","journal-title":"International Journal of Drug Policy"},{"issue":"3","key":"10.1016\/j.drugpo.2019.09.008_bib0038","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.drugpo.2008.10.003","article-title":"Risk environments and drug harms: A social science for harm reduction approach","volume":"20","author":"Rhodes","year":"2009","journal-title":"International Journal of Drug Policy"},{"issue":"2","key":"10.1016\/j.drugpo.2019.09.008_bib0039","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/jurban\/jti053","article-title":"Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: A pilot intervention study","volume":"82","author":"Seal","year":"2005","journal-title":"Journal of Urban Health"},{"issue":"14","key":"10.1016\/j.drugpo.2019.09.008_bib0040","doi-asserted-by":"crossref","first-page":"382","DOI":"10.15585\/mmwr.mm6614a2","article-title":"Characteristics of fentanyl overdose - Massachusetts, 2014-2016","volume":"66","author":"Somerville","year":"2017","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"issue":"9","key":"10.1016\/j.drugpo.2019.09.008_bib0041","doi-asserted-by":"crossref","first-page":"279","DOI":"10.15585\/mmwr.mm6709e1","article-title":"Vital signs: Trends in emergency department visits for suspected opioid overdoses \u2014 United States, July 2016\u2013September 2017","volume":"67","author":"Vivolo-Kantor","year":"2018","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"issue":"3","key":"10.1016\/j.drugpo.2019.09.008_bib0042","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.drugpo.2009.01.003","article-title":"Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA","volume":"21","author":"Wagner","year":"2010","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2019.09.008_bib0043","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f174","article-title":"Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: Interrupted time series analysis","volume":"346","author":"Walley","year":"2013","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.drugpo.2019.09.008_bib0044","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/15563650.2016.1253846","article-title":"Do heroin overdose patients require observation after receiving naloxone?","volume":"55","author":"Willman","year":"2017","journal-title":"Clinical Toxicology"},{"issue":"1","key":"10.1016\/j.drugpo.2019.09.008_bib0045","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/08897077.2015.1132294","article-title":"Barriers to implementation of opioid overdose prevention programs in Ohio","volume":"37","author":"Winstanley","year":"2016","journal-title":"Substance Abuse"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395919302518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395919302518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:36:20Z","timestamp":1777595780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395919302518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":45,"alternative-id":["S0955395919302518"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2019.09.008","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Barriers to naloxone use and acceptance among opioid users, first responders, and emergency department providers in New Hampshire, USA","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2019.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}